Table 1.
Descriptive statistics of patient samples used for the JUP ELISAs.
| Group | FIGO stage | No. | Age | CA125 [kU/L] |
|---|---|---|---|---|
| A) MULTICENTRE DATASET - PLASMA EDTA (FIGURE 3) | ||||
| High grade serous | IA | 18 | 62 (43–84) | 54 (6–11,710) |
| IB | 2 | 60 (52–68) | 1,247 (730–1,763) | |
| IC | 20 | 60 (45–86) | 232 (17–2,323) | |
| II | 23 | 60 (41–78) | 285 (10–2,446) | |
| III | 34 | 66 (39–84) | 816 (47–11,200) | |
| Normal control | – | 109 | 47 (28–86) | 9 (2–54) |
| B) OVARIAN CANCER SUBTYPES - SERUM (FIGURE 4) | ||||
| Endometrioid | IA | 10 | 58 (41–68) | 50 (12–1,564) |
| IC | 5 | 55 (33–90) | 141 (113–1,856) | |
| Mucinous | IA | 9 | 61 (37–72) | 25 (12–1,570) |
| IC | 3 | 45 (29–62) | 98 (35–126) | |
| Clear cell | IA | 9 | 61 (43–82) | 33 (8–593) |
| IB | 1 | 52 | 20 | |
| IC | 1 | 63 | 20 | |
| Normal control | – | 39 | 46 (26–79) | 10 (3–63) |
| C) BREAST CANCER DATASET - PLASMA EDTA | ||||
| Breast cancer | I | 6 | 52 (41–66) | – |
| II | 6 | 61 (46–68) | – | |
| High grade serous | IC | 3 | 50 (45–86) | 292 (289–390) |
| II | 2 | 58 (53–63) | 210 (121–298) | |
| Normal control | – | 7 | 60 (37–72) | 13 (5–24) |
Age and CA125 concentrations are given as median with range in brackets. High grade serous stage IC contains one patient without a known CA125 plasma concentration.